Acquisitions, Philips Partnerships And FDA Approvals Will Expand Market Reach

Published
04 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
AU$0.72
24.8% undervalued intrinsic discount
15 Aug
AU$0.55
Loading
1Y
26.7%
7D
-2.7%

Author's Valuation

AU$0.7

24.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 15%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 21%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25